Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

What is killing Dungarvan Bay’...

00:08:57

What is killing Dungarvan Bay’s Oysters each August?

The Pat Kenny Show

00:08:57


Neither Confirm Nor Deny: Brit...

00:18:28

Neither Confirm Nor Deny: British Intelligence, Lawless Agent Running and the Suppression of Truth

The Pat Kenny Show

00:18:28


Luke O’Neill on Gastritis

00:06:35

Luke O’Neill on Gastritis

The Pat Kenny Show

00:06:35


Ryanair window blowout: How di...

00:08:59

Ryanair window blowout: How did it happen?

The Pat Kenny Show

00:08:59